Ann: Change of Director's Interest Notice-BOT.AX, page-5

Was suggested to look at BOT and managed to pick up a few parcels in the mid 4c range. Massive market and very little in the way of new breakthrough pharmaceuticals has come to market for many years. Management have vast experience in obtaining FDA approvals for products and the use of a synthetic cannabinoid leads to a much easier pathway to FDA approval.
Would be appearing on some price and volume scans and suspect the newsflow should keep the momentum going with a minuscule MC and market that is crying out for new products in the acne/dermatitis market.